THYTECH
Rafael C. has work experience spanning over several years in various organizations. From 2004 to 2007, they worked as a Postdoctoral Researcher at EPFL (École polytechnique fédérale de Lausanne). Following this, they joined HUG - Hopitaux Universitaires de Genève as an Adjunct Research Professor from 2007 to 2008. In 2008, they joined Instituto de Investigación Sanitaria Gregorio Marañón as a Group Leader. Their most recent work experience began in 2022 at THYTECH, where they hold the position of Funding Director.
Rafael C. completed their Doctorado en Biología from the Universidad Complutense de Madrid in the field of study of Biología, general. This degree was completed in an undisclosed year before 2004. Later, they pursued a Doctorado en Medicina y Cirugía from the Universidad Autónoma de Madrid, specializing in the field of study of Medicina. This degree was completed in the year 2014. No further information is provided about their education history.
This person is not in any teams
THYTECH
THYTECH is a spin-off of the Gregorio Marañón Health Research Institute (IISGM) that was created with the aim of transferring to the patient our patented technology for the treatment of diseases related to immune disorders. The company arises from the work carried out by the researchers of the Immunoregulation Laboratory, and our main asset is a cellular therapy with thyTreg cells that is pioneering in the world that can establish a new paradigm in the prevention of transplant rejection and in the treatment of autoimmune diseases and clinical worsening of COVID patients.